Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy

Area of Science:

• Neurobiology
• Neurodegenerative Diseases
• Biochemistry

Background:

• Multiple system atrophy (MSA) is a progressive neurodegenerative disorder.
• Myelin instability is suggested as an early pathological event in MSA.
• Lipids are crucial for myelin integrity and function, and implicated in MSA.

Purpose of the Study:

• To investigate alterations in myelin lipid levels and distribution in the MSA brain.
• To quantify specific myelin lipids (sphingomyelin, sulfatide, galactoceramide) in affected and unaffected white matter.

Main Methods:

• Quantitative analysis of sphingomyelin, sulfatide, and galactoceramide levels.
• Comparison of lipid levels in white matter regions under the motor cortex (affected) versus visual cortex (unaffected).
• Assessment of lipid species distribution, including fatty acid chain length and content.

Main Results:

• Significant decreases (40-69%) in most sphingomyelin, sulfatide, and galactoceramide species were observed in affected MSA white matter.
• No significant shifts in the distribution of lipid species were found.
• Reduced lipid levels correlated with increased alpha-synuclein expression.

Conclusions:

• Absolute levels of myelin lipids, not their distribution, are altered in MSA.
• Evidence suggests myelin lipid dysfunction is involved in MSA pathology.
• Dysregulation of myelin lipids may initiate myelin instability in MSA pathogenesis.